ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

LGND Ligand Pharmaceuticals Incorporated

106.22
-3.73 (-3.39%)
18 Mar 2025 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 43.98M26.37M34.99M28.1M30.98M41.53M51.81M42.81M
Operating Income 14.21M-1.98M3.08M-3.36M2.99M-19.1M10.96M-2.39M
Pre Tax Income 55.54M3.17M-12.14M17.1M113.45M-65.39M-6.34M-39.2M
Net Income 41.95M2.29M-10.27M18.19M86.14M-51.91M-7.17M-31.09M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT 14.81M-2.86M-1.22M1.38M600k-48.33M162k-14.91M
EBITDA 23.7M24.59M-4.47M4.63M11.75M16.24M19.95M10.33M
Year End 31 December 2024 20172018201920202021202220232024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 141.1M251.45M120.28M186.42M314.73M196.25M131.31M167.13M
Operating Income 66.03M213.91M-5.72M8.73M78.9M3.04M9.82M-7.55M
Pre Tax Income 57.23M173.33M796.64M-10.54M47.3M36.01M63.66M2.52M
Net Income 12.56M143.32M629.3M-2.99M57.14M-33.36M52.15M-4.03M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 0.5946.90237.407-0.1863.408-1.9682.991-0.213
EBIT 68.63M207.61M801.07M25.74M70.04M7.22M9.99M-62.47M
EBITDA 78.55M230.61M38.01M36.25M129.96M41.07M46.34M58.28M